Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerevel Therapeutics Hldg Inc (NQ: CERE )

35.35 +0.39 (+1.12%)
Streaming Delayed Price Updated: 9:56 AM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,145
Open 34.88
Bid (Size) 35.20 (1)
Ask (Size) 35.50 (2)
Prev. Close 34.96
Today's Range 34.88 - 35.55
52wk Range 19.86 - 41.46
Shares Outstanding 8,830,700
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
 
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga

Performance

YTD
+14.22%
+14.22%
1 Month
+15.00%
+15.00%
3 Month
+30.39%
+30.39%
6 Month
-3.91%
-3.91%
1 Year
+22.83%
+22.83%

More News

Read More
Data Shows Cerevel's Emraclidine Does Not Induce High Blood Pressure In Schizophrenia Patients
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
Via Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
Via Benzinga
Why Cerevel Therapeutics Holdings Shares Are Nosediving
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
Via Benzinga
Analyst Ratings for Cerevel Therapeutics
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
Via Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
Via Benzinga
Cerevel Therapeutics Shares Are Falling: Here's Why
Via Benzinga
Bumble, Hanesbrands, Sonos And Some Other Big Losers From Thursday
Via Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Via Benzinga
Here's Why Cerevel Therapeutics Stock Is Getting Hammered Today
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.